| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
129,778 |
114,142 |
$12.24M |
| S9083 |
Global fee urgent care centers |
104,678 |
95,474 |
$9.22M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
81,102 |
80,602 |
$7.24M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
59,520 |
55,762 |
$5.93M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
22,441 |
22,411 |
$2.19M |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
47,850 |
41,945 |
$2.08M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
62,686 |
56,927 |
$983K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,698 |
2,431 |
$246K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13,465 |
12,204 |
$166K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,845 |
1,751 |
$164K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,445 |
1,438 |
$137K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,861 |
4,026 |
$75K |
| 0011A |
|
696 |
694 |
$23K |
| 0012A |
|
572 |
569 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
477 |
465 |
$17K |
| 99215 |
Prolong outpt/office vis |
159 |
159 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,469 |
3,432 |
$10K |
| 99072 |
|
6,899 |
6,444 |
$4K |
| 99000 |
|
28,221 |
26,449 |
$4K |
| 0004A |
|
80 |
80 |
$4K |
| 0064A |
|
89 |
89 |
$3K |
| 81025 |
|
1,506 |
1,464 |
$3K |
| 0001A |
|
58 |
58 |
$2K |
| 0002A |
|
52 |
52 |
$2K |
| 81003 |
|
3,471 |
3,395 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
58 |
58 |
$2K |
| 99201 |
|
18 |
18 |
$1K |
| 0124A |
|
32 |
32 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,499 |
1,484 |
$949.34 |
| 0013A |
|
21 |
21 |
$908.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
180 |
169 |
$706.73 |
| 87807 |
|
187 |
185 |
$681.75 |
| 0003A |
|
12 |
12 |
$550.00 |
| 73562 |
|
53 |
52 |
$291.39 |
| 71046 |
Radiologic examination, chest; 2 views |
91 |
91 |
$280.37 |
| 73110 |
|
37 |
35 |
$279.69 |
| 93000 |
|
82 |
81 |
$189.00 |
| 90674 |
|
31 |
31 |
$118.40 |
| 73140 |
|
32 |
32 |
$104.02 |
| 73630 |
|
40 |
40 |
$102.67 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
157 |
157 |
$96.55 |
| 73030 |
|
17 |
17 |
$81.31 |
| 72100 |
|
31 |
31 |
$68.17 |
| 73130 |
|
33 |
31 |
$43.80 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
87 |
87 |
$28.97 |
| 73610 |
|
41 |
39 |
$28.80 |
| 90715 |
|
12 |
12 |
$23.93 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
90 |
81 |
$22.24 |
| 82948 |
|
38 |
37 |
$11.42 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
30 |
29 |
$5.46 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
14 |
$1.83 |
| J7510 |
Prednisolone oral, per 5 mg |
21 |
21 |
$1.34 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
46 |
45 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
44 |
44 |
$0.00 |
| 99429 |
|
15 |
13 |
$0.00 |
| 99499 |
|
14 |
14 |
$0.00 |